Peripheral nerve injury recovery enhanced by ceftriaxone: a preclinical investigation

ABSTRACT Purpose: To evaluate ceftriaxone’s potential in enhancing peripheral nerve injuries (PNIs) recovery. Methods: Thirty male Wistar rats were divided into control (no surgery), vehicle (sciatic nerve injury + 0.9% NaCl), and ceftriaxone (sciatic nerve injury + 50 mg/kg/day ceftriaxone) group...

Full description

Saved in:
Bibliographic Details
Main Authors: Berkin Gunar, Ejder Saylav Bora, Osman Mert Topkar, Özgür Baysal, Ziya Shammadli, Oytun Erbas
Format: Article
Language:English
Published: Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia 2025-07-01
Series:Acta Cirúrgica Brasileira
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502025000100228&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849424855969038336
author Berkin Gunar
Ejder Saylav Bora
Osman Mert Topkar
Özgür Baysal
Ziya Shammadli
Oytun Erbas
author_facet Berkin Gunar
Ejder Saylav Bora
Osman Mert Topkar
Özgür Baysal
Ziya Shammadli
Oytun Erbas
author_sort Berkin Gunar
collection DOAJ
description ABSTRACT Purpose: To evaluate ceftriaxone’s potential in enhancing peripheral nerve injuries (PNIs) recovery. Methods: Thirty male Wistar rats were divided into control (no surgery), vehicle (sciatic nerve injury + 0.9% NaCl), and ceftriaxone (sciatic nerve injury + 50 mg/kg/day ceftriaxone) groups. Treatments were administered intraperitoneally for 12 weeks. Functional recovery was assessed using inclined plane tests and electromyography. Sciatic nerve regeneration was evaluated via histology, nerve growth factor (NGF) immunohistochemistry, and enzyme-linked immunosorbent assay. Results: Compared to the control group, inclined plane test scores, nerve action potentials, NGF expression, axon counts, and diameters were diminished in both injury groups (p 0.001). However, these parameters were significantly improved in the ceftriaxone group compared to the vehicle group (p 0.001). Increased fibrosis was observed in the ceftriaxone group. Conclusion: Ceftriaxone demonstrates potential as a pharmacological agent for PNI recovery by enhancing nerve regeneration and functional outcomes. Further studies are warranted to elucidate its mechanisms.
format Article
id doaj-art-eab24903a20e4996a6faef2938e539b3
institution Kabale University
issn 1678-2674
language English
publishDate 2025-07-01
publisher Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
record_format Article
series Acta Cirúrgica Brasileira
spelling doaj-art-eab24903a20e4996a6faef2938e539b32025-08-20T03:29:58ZengSociedade Brasileira para o Desenvolvimento da Pesquisa em CirurgiaActa Cirúrgica Brasileira1678-26742025-07-014010.1590/acb404625Peripheral nerve injury recovery enhanced by ceftriaxone: a preclinical investigationBerkin Gunarhttps://orcid.org/0000-0001-9409-1510Ejder Saylav Borahttps://orcid.org/0000-0002-2448-2337Osman Mert Topkarhttps://orcid.org/0000-0003-2452-1954Özgür Baysalhttps://orcid.org/0000-0001-5150-8857Ziya Shammadlihttps://orcid.org/0000-0003-1501-0108Oytun Erbashttps://orcid.org/0000-0001-5427-8428ABSTRACT Purpose: To evaluate ceftriaxone’s potential in enhancing peripheral nerve injuries (PNIs) recovery. Methods: Thirty male Wistar rats were divided into control (no surgery), vehicle (sciatic nerve injury + 0.9% NaCl), and ceftriaxone (sciatic nerve injury + 50 mg/kg/day ceftriaxone) groups. Treatments were administered intraperitoneally for 12 weeks. Functional recovery was assessed using inclined plane tests and electromyography. Sciatic nerve regeneration was evaluated via histology, nerve growth factor (NGF) immunohistochemistry, and enzyme-linked immunosorbent assay. Results: Compared to the control group, inclined plane test scores, nerve action potentials, NGF expression, axon counts, and diameters were diminished in both injury groups (p 0.001). However, these parameters were significantly improved in the ceftriaxone group compared to the vehicle group (p 0.001). Increased fibrosis was observed in the ceftriaxone group. Conclusion: Ceftriaxone demonstrates potential as a pharmacological agent for PNI recovery by enhancing nerve regeneration and functional outcomes. Further studies are warranted to elucidate its mechanisms.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502025000100228&lng=en&tlng=enNerve Growth FactorsCeftriaxoneExperimental Study
spellingShingle Berkin Gunar
Ejder Saylav Bora
Osman Mert Topkar
Özgür Baysal
Ziya Shammadli
Oytun Erbas
Peripheral nerve injury recovery enhanced by ceftriaxone: a preclinical investigation
Acta Cirúrgica Brasileira
Nerve Growth Factors
Ceftriaxone
Experimental Study
title Peripheral nerve injury recovery enhanced by ceftriaxone: a preclinical investigation
title_full Peripheral nerve injury recovery enhanced by ceftriaxone: a preclinical investigation
title_fullStr Peripheral nerve injury recovery enhanced by ceftriaxone: a preclinical investigation
title_full_unstemmed Peripheral nerve injury recovery enhanced by ceftriaxone: a preclinical investigation
title_short Peripheral nerve injury recovery enhanced by ceftriaxone: a preclinical investigation
title_sort peripheral nerve injury recovery enhanced by ceftriaxone a preclinical investigation
topic Nerve Growth Factors
Ceftriaxone
Experimental Study
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502025000100228&lng=en&tlng=en
work_keys_str_mv AT berkingunar peripheralnerveinjuryrecoveryenhancedbyceftriaxoneapreclinicalinvestigation
AT ejdersaylavbora peripheralnerveinjuryrecoveryenhancedbyceftriaxoneapreclinicalinvestigation
AT osmanmerttopkar peripheralnerveinjuryrecoveryenhancedbyceftriaxoneapreclinicalinvestigation
AT ozgurbaysal peripheralnerveinjuryrecoveryenhancedbyceftriaxoneapreclinicalinvestigation
AT ziyashammadli peripheralnerveinjuryrecoveryenhancedbyceftriaxoneapreclinicalinvestigation
AT oytunerbas peripheralnerveinjuryrecoveryenhancedbyceftriaxoneapreclinicalinvestigation